Apyx Medical Corporation Reports Second Quarter 2025 Financial Results
Apyx Medical Corporation (APYX)
Last apyx medical corporation earnings: 3/16 04:27 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
Successfully launched AYON Body Contouring System™ to key surgeons in critical geographies; plan for commercial launch in September 2025Initiated commercial sales of Renuvion® in China with strong clinical interest and completed initial proceduresBased on pre-sales of AYON, the Company increased its total revenue guidance for FY2025 to a range of $50.0 million to $52.0 millionManagement to host a conference call today at 4:30 p.m. ET CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its quarter ended June 30, 2025. Recent Financial and Operating Highlights: Reported total revenue of $11.4 million in the second quarter of 2025, compared to $12.1 million in the comparable period last year. Advanced Energy revenu
Show less
Read more
Impact Snapshot
Event Time:
APYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APYX alerts
High impacting Apyx Medical Corporation news events
Weekly update
A roundup of the hottest topics
APYX
News
- What The AYON Launch Means For Apyx Medical's Evolving Story And Valuation [Yahoo! Finance]Yahoo! Finance
- Apyx Medical (NASDAQ:APYX) was upgraded by analysts at Zacks Research to a "hold" rating.MarketBeat
- Apyx Medical (NASDAQ:APYX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.MarketBeat
- Apyx Medical (NASDAQ:APYX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.MarketBeat
- Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South KoreaGlobeNewswire
APYX
Earnings
- 3/13/25 - Beat
APYX
Sec Filings
- 12/17/25 - Form EFFECT
- 12/12/25 - Form 8-K
- 12/1/25 - Form S-3
- APYX's page on the SEC website